Nerve and Muscle Physiology

⚡ The Bioelectrical Command Center: Nerve and Muscle Mastery

Your body executes every thought, breath, and heartbeat through an elegant bioelectrical system where nerves and muscles communicate at millisecond speed. You'll discover how cells generate electrical signals from ion gradients, propagate action potentials along axons, translate chemical messages across synapses, and couple electrical excitation to mechanical contraction. We'll connect molecular mechanisms to muscle fiber specialization and then apply this framework to interpret clinical conditions from myasthenia gravis to malignant hyperthermia, building your diagnostic reasoning from first principles.

The integration of electrical and mechanical systems in human physiology represents one of medicine's most elegant examples of structure-function relationships. Every clinical decision in cardiology, neurology, and anesthesiology depends on understanding how electrical signals translate into mechanical work, how ion gradients create action potentials, and how calcium orchestrates the molecular dance of contraction.

Connect these bioelectrical foundations through systematic exploration of membrane dynamics, action potential generation, neurotransmitter systems, and contractile mechanisms to understand the complete spectrum of neuromuscular physiology that governs human movement and cardiac function.

---

🔋 Membrane Potential Mastery: The Cellular Battery System

Ionic Foundation Architecture

The membrane potential emerges from asymmetric ion distribution across the lipid bilayer:

• Intracellular Environment

  • K⁺ concentration: 140 mEq/L (30x higher than extracellular)
  • Na⁺ concentration: 10 mEq/L (14x lower than extracellular)
  • Large anions (proteins): 138 mEq/L (impermeant)
    • Organic phosphates: 75 mEq/L
    • Protein anions: 63 mEq/L

• Extracellular Environment

  • Na⁺ concentration: 142 mEq/L (primary cation)
  • K⁺ concentration: 4.5 mEq/L (tightly regulated)
  • Cl⁻ concentration: 103 mEq/L (follows electrical gradient)
    • HCO₃⁻ concentration: 28 mEq/L
    • Other anions: 11 mEq/L

📌 Remember: KING - K⁺ Inside, Na⁺ Gets pumped out. K⁺ dominates intracellular space (140 mEq/L), while Na⁺ rules extracellular fluid (142 mEq/L), creating the -70mV driving force for excitability.

The Na⁺/K⁺-ATPase maintains ionic gradients through electrogenic transport:

• Energy Requirements: 25-40% of total cellular ATP consumption
• Transport Stoichiometry: 3 Na⁺ out : 2 K⁺ in per ATP molecule
• Electrogenic Contribution: -5 to -10mV direct voltage contribution
• Pump Density: 100-200 pumps/μm² in excitable membranes

⭐ Clinical Pearl: Digitalis toxicity occurs when Na⁺/K⁺-ATPase inhibition reaches >50%, causing intracellular Na⁺ accumulation, reverse Na⁺/Ca²⁺ exchange, and increased contractility that progresses to arrhythmias at >80% inhibition.

Goldman-Hodgkin-Katz Integration

The membrane potential reflects weighted contributions of all permeant ions:

$$V_m = \frac{RT}{F} \ln\left(\frac{P_K[K^+]o + P{Na}[Na^+]o + P{Cl}[Cl^-]_i}{P_K[K^+]i + P{Na}[Na^+]i + P{Cl}[Cl^-]_o}\right)$$

• Potassium Dominance: P_K = 1.0 (reference permeability)
• Sodium Contribution: P_{Na} = 0.04 (4% of K⁺ permeability)
• Chloride Influence: P_{Cl} = 0.45 (45% of K⁺ permeability)

💡 Master This: Membrane potential changes predict drug responses - 10mV depolarization doubles Na⁺ channel availability, while 10mV hyperpolarization increases action potential threshold by 15-20%, explaining why hyperkalemia (K⁺ >5.5 mEq/L) initially increases excitability before causing conduction block.

Understanding membrane potential dynamics provides the foundation for predicting how electrolyte imbalances, medications, and pathological conditions affect cellular excitability across all organ systems.

---

⚡ Action Potential Architecture: The Electrical Signal Highway

Voltage-Gated Channel Orchestration

Action potential generation requires precise coordination of multiple ion channel populations:

• Sodium Channel Dynamics

  • Activation threshold: -55mV (15mV above resting potential)
  • Peak conductance: 500-1000 pS per channel
  • Inactivation time constant: 0.5-1.0 ms at body temperature
    • Fast inactivation: h-gate closure within 1-2 ms
    • Slow inactivation: cumulative during high-frequency firing

• Potassium Channel Contributions

  • Delayed rectifier activation: 10-20 ms delay after depolarization
  • Peak conductance: 20-50 pS per channel (sustained)
  • A-type K⁺ channels: rapid inactivation within 5-10 ms
    • Transient outward current: shapes action potential duration
    • Recovery from inactivation: 50-100 ms at -70mV

📌 Remember: SNAP - Sodium Naviates Action Potentials. Na⁺ channels open at -55mV, reach peak at +30mV, then inactivate within 1ms, while K⁺ channels activate slowly but sustain repolarization for 10-20ms.

Action potential conduction speed depends on multiple biophysical factors:

• Fiber Classification by Conduction Velocity:

  • Aα fibers: 70-120 m/s (large myelinated motor neurons)
  • Aβ fibers: 30-70 m/s (touch, pressure sensory)
  • Aδ fibers: 5-30 m/s (small myelinated pain, temperature)
  • C fibers: 0.5-2 m/s (unmyelinated pain, autonomic)

• Myelination Effects:

  • Node spacing: 1-2mm intervals optimize conduction
  • Myelin thickness: 20-100 wraps increase membrane resistance
  • Saltatory jumps: 50-fold velocity increase over unmyelinated

⭐ Clinical Pearl: Multiple sclerosis reduces conduction velocity by 50-80% in demyelinated fibers, causing the Uhthoff phenomenon where 1°C temperature increase further slows conduction by 10-15%, explaining symptom worsening with fever or exercise.

Refractory Period Mechanisms

Post-excitation recovery involves distinct phases of channel availability:

• Absolute Refractory Period

  • Duration: 1-2 ms in most neurons
  • Mechanism: Na⁺ channel inactivation (h-gates closed)
  • Clinical significance: Limits maximum firing frequency to 500-1000 Hz

• Relative Refractory Period

  • Duration: 5-15 ms depending on fiber type
  • Mechanism: Elevated K⁺ conductance + partial Na⁺ recovery
  • Threshold elevation: 10-20 mV above normal

💡 Master This: Refractory periods prevent bidirectional propagation and limit firing frequency - absolute refractory period determines maximum neural firing rate (~500 Hz), while relative refractory period creates the chronaxie (minimum stimulus duration at 2x threshold) used in pacemaker programming.

Excitability Modulation Factors

Multiple physiological and pathological conditions alter action potential generation:

• Electrolyte Effects on Excitability:
  • Hyperkalemia (K⁺ >5.5 mEq/L): Initial depolarization increases excitability
  • Severe hyperkalemia (K⁺ >7.0 mEq/L): Na⁺ channel inactivation blocks conduction
  • Hypocalcemia (Ca²⁺ <8.5 mg/dL): Increased Na⁺ permeability causes hyperexcitability
  • Hyponatremia (Na⁺ <135 mEq/L): Reduced driving force decreases action potential amplitude

Understanding action potential mechanisms provides the foundation for interpreting how local anesthetics block nerve conduction, how antiarrhythmic drugs modify cardiac excitability, and how electrolyte disorders create characteristic ECG changes and neurological symptoms.

---

🎯 Neurotransmission Precision: The Chemical Signal Network

Neurotransmitter Release Machinery

Synaptic transmission requires precise molecular coordination for vesicle fusion:

• SNARE Protein Complex

  • Syntaxin: t-SNARE anchored in presynaptic membrane
  • SNAP-25: t-SNARE with dual membrane anchors
  • Synaptobrevin: v-SNARE on synaptic vesicle membrane
    • Complex formation: ATP-independent but Ca²⁺-triggered
    • Fusion pore: 1-2 nm initial diameter, expands to 20-40 nm

• Calcium Sensor Mechanisms

  • Synaptotagmin: Ca²⁺ sensor with dual C2 domains
  • Ca²⁺ binding affinity: Kd = 10-100 μM (physiological range)
  • Cooperativity: 4-5 Ca²⁺ ions required for vesicle fusion
    • Distance dependence: <100 nm from Ca²⁺ channels for fast release
    • Temporal precision: 200-500 μs from Ca²⁺ influx to fusion

📌 Remember: SNARE-SNAP - Syntaxin Needs All Required Elements, SNAP-25 Navigate Anchoring Points. The t-SNAREs (syntaxin + SNAP-25) capture v-SNAREs (synaptobrevin) when Ca²⁺ >10 μM triggers synaptotagmin binding.

Neurotransmitter receptors fall into two major functional categories:

• Ionotropic Receptors (Ligand-Gated Ion Channels)

  • Response time: 1-5 ms (direct channel opening)
  • Duration: 10-100 ms (limited by desensitization)
  • Selectivity: Ion-specific permeability changes
    • Nicotinic AChR: Na⁺/K⁺ permeability, +10mV reversal potential
    • GABA-A: Cl⁻ permeability, -70mV reversal potential
    • NMDA: Ca²⁺/Na⁺/K⁺ with Mg²⁺ voltage block

• Metabotropic Receptors (G-Protein Coupled)

  • Response time: 50-500 ms (second messenger cascades)
  • Duration: seconds to minutes (enzyme-mediated)
  • Amplification: 100-1000x signal amplification
    • Gs coupling: ↑ cAMP → PKA activation
    • Gq coupling: ↑ IP₃/DAG → PKC activation
    • Gi/o coupling: ↓ cAMP → reduced PKA activity

⭐ Clinical Pearl: Myasthenia gravis reduces nicotinic receptor density by 70-90% through autoantibodies, requiring 3-4x normal ACh release for muscle activation. This explains the decremental response on repetitive nerve stimulation and >50% improvement with anticholinesterases.

Synaptic Plasticity Mechanisms

Activity-dependent changes in synaptic strength provide the basis for learning and memory:

• Short-Term Plasticity (milliseconds to minutes)

  • Facilitation: ↑ residual Ca²⁺ enhances subsequent release
  • Depression: Vesicle depletion reduces release probability
  • Post-tetanic potentiation: Enhanced Ca²⁺ buffering for 1-5 minutes

• Long-Term Plasticity (hours to lifetime)

  • LTP induction: NMDA receptor activation requires depolarization + glutamate
  • Ca²⁺ threshold: >1 μM for >1 second triggers CaMKII autophosphorylation
  • Protein synthesis: New AMPA receptors inserted within 30-60 minutes

💡 Master This: Synaptic plasticity follows the Hebbian rule - "neurons that fire together, wire together." LTP requires coincident presynaptic glutamate release and postsynaptic depolarization to remove Mg²⁺ block from NMDA receptors, allowing Ca²⁺ influx that triggers CaMKII activation and AMPA receptor trafficking.

Understanding neurotransmission mechanisms provides the foundation for predicting how psychiatric medications modify synaptic function, how neurotoxins disrupt neural communication, and how synaptic plasticity underlies learning, memory, and addiction processes.

---

🔬 Excitation-Contraction Coupling: The Force Generation Engine

Calcium Release Mechanisms by Muscle Type

Each muscle type employs distinct strategies for calcium mobilization:

• Skeletal Muscle (Voltage-Induced Calcium Release)

  • Dihydropyridine receptors: Voltage sensors in T-tubule membrane
  • Ryanodine receptors: Mechanically coupled to DHPRs (no Ca²⁺ influx required)
  • SR calcium content: 1-2 mM total, 100-200 μM free
    • Release kinetics: Peak at 2-5 ms, decay by 20-50 ms
    • Calcium transient: 1-10 μM peak cytoplasmic concentration

• Cardiac Muscle (Calcium-Induced Calcium Release)

  • L-type calcium channels: Trigger calcium (10-15% of total)
  • Ryanodine receptors: Calcium-sensitive release channels
  • SR calcium load: Determines contraction strength (Frank-Starling mechanism)
    • Release amplification: 10-20x trigger calcium
    • Calcium cycling: 70% reuptake by SERCA, 30% extrusion by NCX

• Smooth Muscle (IP₃-Mediated and Voltage-Dependent)

  • IP₃ receptors: Second messenger-gated calcium release
  • Voltage-gated calcium channels: Direct calcium influx
  • Calcium sensitivity: Modulated by protein kinases
    • Calmodulin binding: 4 Ca²⁺ ions required for activation
    • Myosin light chain kinase: Ca²⁺-calmodulin dependent

📌 Remember: CICR-VICC-IP3 - Cardiac uses Calcium-Induced Calcium Release, skeletal uses Voltage-Induced Calcium Coupling, smooth uses IP₃ pathways. Each mechanism matches the functional demands: skeletal = speed, cardiac = graded force, smooth = sustained contraction.

The conversion of calcium signals into mechanical force involves highly conserved molecular mechanisms:

• Striated Muscle Regulation (Troponin-Tropomyosin System)

  • Troponin C: 4 Ca²⁺ binding sites (2 high-affinity, 2 low-affinity)
  • Cooperative binding: Hill coefficient = 2-3 (steep Ca²⁺ sensitivity)
  • Tropomyosin position: Blocks myosin binding at low [Ca²⁺]
    • Ca²⁺ binding: Shifts tropomyosin by 25-30 Å
    • Myosin binding: Further shift exposes additional sites

• Smooth Muscle Regulation (Myosin Light Chain System)

  • Myosin light chain kinase: Ca²⁺-calmodulin activated
  • Myosin phosphatase: Constitutively active (determines relaxation)
  • Phosphorylation level: Determines cross-bridge cycling rate
    • Maximal activation: 0.6-0.8 mol PO₄/mol myosin
    • Force maintenance: Latch state at low [Ca²⁺]

⭐ Clinical Pearl: Dantrolene blocks ryanodine receptors, reducing SR calcium release by 70-90% in skeletal muscle. This mechanism treats malignant hyperthermia (RYR1 mutations causing excessive calcium release) and provides muscle relaxation without affecting cardiac or smooth muscle significantly.

Force-Frequency and Length-Tension Relationships

Muscle force generation depends on both activation frequency and mechanical factors:

• Force-Frequency Relationship

  • Skeletal muscle: Summation at >20 Hz, tetanus at >50 Hz
  • Cardiac muscle: Positive force-frequency (Bowditch effect)
  • Smooth muscle: Optimal frequency varies 0.1-10 Hz by tissue

• Length-Tension Relationship

  • Optimal length: Maximum actin-myosin overlap (2.0-2.2 μm sarcomere length)
  • Passive tension: Titin and collagen contribute at >2.4 μm
  • Active tension: Decreases with under-stretch (<1.8 μm) or over-stretch (>2.6 μm)

💡 Master This: The Frank-Starling mechanism in cardiac muscle optimizes stroke volume through length-dependent calcium sensitivity - increased venous return stretches cardiac fibers, increasing troponin C calcium affinity and cross-bridge force generation without requiring increased [Ca²⁺]ᵢ.

Understanding excitation-contraction coupling provides the foundation for predicting how calcium channel blockers affect cardiac contractility, how neuromuscular blocking agents prevent skeletal muscle contraction, and how smooth muscle relaxants treat conditions from hypertension to asthma.

---

⚙️ Muscle Fiber Specialization: The Performance Optimization Matrix

Fiber Type Classification Matrix

Muscle fibers are classified based on contractile and metabolic properties:

• Type I (Slow-Twitch, Oxidative)

  • Myosin ATPase: Low activity (slow cross-bridge cycling)
  • Contraction time: 100-120 ms to peak tension
  • Fatigue resistance: High (>60 minutes sustained activity)
    • Mitochondrial density: 15-20% of fiber volume
    • Capillary density: 4-6 capillaries per fiber
    • Oxidative enzymes: High SDH, COX activity

• Type IIa (Fast-Twitch, Oxidative-Glycolytic)

  • Myosin ATPase: High activity (fast cross-bridge cycling)
  • Contraction time: 50-70 ms to peak tension
  • Fatigue resistance: Moderate (15-30 minutes)
    • Mitochondrial density: 8-12% of fiber volume
    • Glycolytic capacity: High PFK, LDH activity
    • Power output: 3-4x higher than Type I

• Type IIx (Fast-Twitch, Glycolytic)

  • Myosin ATPase: Highest activity (fastest cycling)
  • Contraction time: 25-40 ms to peak tension
  • Fatigue resistance: Low (2-5 minutes)
    • Mitochondrial density: 2-5% of fiber volume
    • Glycolytic enzymes: Highest activity
    • Power output: 5-8x higher than Type I

📌 Remember: SOG-FOG-FG - Slow Oxidative Green (Type I), Fast Oxidative Glycolytic (Type IIa), Fast Glycolytic (Type IIx). Contraction speed increases (120ms → 50ms → 25ms), while fatigue resistance decreases (>60min → 15-30min → 2-5min).

Each fiber type employs distinct metabolic strategies for ATP regeneration:

• Oxidative Metabolism (Type I Dominant)

  • Oxygen consumption: 3-5 mL O₂/min/100g at rest
  • Substrate preference: 60% fat, 40% carbohydrate during moderate exercise
  • ATP yield: 36-38 mol ATP/mol glucose (complete oxidation)
    • Fatty acid oxidation: 129 mol ATP/mol palmitate
    • Mitochondrial respiration: Rate-limiting for sustained power

• Glycolytic Metabolism (Type IIx Dominant)

  • Lactate production: >20 mM during maximal exercise
  • ATP regeneration rate: 2-3x faster than oxidative metabolism
  • ATP yield: 2-3 mol ATP/mol glucose (anaerobic glycolysis)
    • Phosphocreatine system: Immediate energy for 5-10 seconds
    • Glycolytic capacity: Determines peak power output

⭐ Clinical Pearl: Muscle biopsy fiber typing helps diagnose mitochondrial myopathies - patients show >90% Type I fibers with ragged-red appearance due to mitochondrial proliferation, explaining exercise intolerance and elevated lactate even during low-intensity exercise.

Calcium Handling Specialization

Fiber types differ significantly in calcium release and reuptake kinetics:

• Sarcoplasmic Reticulum Density

  • Type I: 6-8% of fiber volume (moderate SR)
  • Type IIa: 10-12% of fiber volume (high SR)
  • Type IIx: 12-15% of fiber volume (highest SR)

• Calcium ATPase Isoforms

  • SERCA1: Fast calcium reuptake (Type II fibers)
  • SERCA2a: Moderate reuptake rate (Type I fibers)
  • Parvalbumin: Calcium buffer (high in Type II)
    • Binding capacity: 2 Ca²⁺ per molecule
    • Concentration: 0.5-2.0 mM in fast fibers

• Relaxation Kinetics

  • Type I: Relaxation half-time = 80-120 ms
  • Type IIa: Relaxation half-time = 40-60 ms
  • Type IIx: Relaxation half-time = 20-30 ms

💡 Master This: Fast-twitch fibers achieve rapid relaxation through high SERCA density and parvalbumin buffering, enabling tetanic fusion at >100 Hz stimulation frequencies. This explains why fast muscles can generate smooth tetanic contractions while slow muscles show visible twitches at similar stimulation rates.

Training-Induced Adaptations

Muscle fibers demonstrate remarkable plasticity in response to different training stimuli:

• Endurance Training Adaptations

  • Mitochondrial biogenesis: 50-100% increase in oxidative enzymes
  • Capillarization: 15-25% increase in capillary density
  • Fiber type shift: IIx → IIa → I (limited conversion)
    • PGC-1α upregulation: Master regulator of mitochondrial biogenesis
    • VEGF expression: Promotes angiogenesis

• Resistance Training Adaptations

  • Fiber hypertrophy: 20-50% increase in cross-sectional area
  • Myofibrillar protein synthesis: Enhanced actin/myosin content
  • Glycolytic capacity: Increased enzyme activity
    • Type II recruitment: Preferential fast-fiber growth
    • Neural adaptations: Improved motor unit synchronization

Understanding muscle fiber specialization provides the foundation for designing optimal training programs, predicting responses to different exercise modalities, and explaining why certain individuals excel in endurance versus power activities.

---

🎯 Clinical Integration Mastery: The Diagnostic and Therapeutic Arsenal

Essential Clinical Correlations Matrix

Nerve and muscle physiology directly explains major clinical presentations:

• Electrolyte Disorders and Excitability

  • Hyperkalemia (K⁺ >5.5 mEq/L): Initial hyperexcitability → conduction block

    • ECG changes: Peaked T-waves → widened QRS → sine wave
    • Mechanism: Depolarized RMP → Na⁺ channel inactivation
    • Treatment threshold: K⁺ >6.5 mEq/L requires immediate intervention

  • Hypocalcemia (Ca²⁺ <8.5 mg/dL): Increased membrane excitability

    • Clinical signs: Chvostek sign (facial nerve hyperexcitability)
    • Mechanism: Reduced Ca²⁺ screening → increased Na⁺ permeability
    • Tetany threshold: Ionized Ca²⁺ <1.0 mg/dL

• Neuromuscular Junction Disorders

  • Myasthenia Gravis: 70-90% reduction in functional AChRs

    • Decremental response: >10% amplitude decrease on 3 Hz stimulation
    • Edrophonium test: >50% improvement in 2-5 minutes
    • Treatment: AChE inhibitors increase ACh availability 5-10x

  • Lambert-Eaton Syndrome: Presynaptic Ca²⁺ channel antibodies

    • Incremental response: >100% amplitude increase on 50 Hz stimulation
    • Autonomic symptoms: Dry mouth, constipation (>80% patients)

📌 Remember: HIKE-LOCA - Hyperkalemia Inactivates, K+ Elevation blocks; LOw CAlcium causes tetany. Hyperkalemia initially depolarizes (peaked T-waves) then blocks (wide QRS), while hypocalcemia hyperexcites (Chvostek, Trousseau signs).

Understanding nerve and muscle physiology predicts drug actions and side effects:

• Sodium Channel Blockers

  • Local anesthetics: Use-dependent block (preferential binding to open/inactivated states)

    • Onset time: pKa-dependent (lidocaine pKa = 7.9, 65% ionized at pH 7.4)
    • Duration: Protein binding and lipophilicity determine tissue residence
    • Systemic toxicity: CNS symptoms at 5-10 μg/mL, cardiac at >15 μg/mL

  • Antiarrhythmics: Class I agents modify cardiac action potentials

    • Class Ia: Moderate Na⁺ block + K⁺ block (quinidine, procainamide)
    • Class Ib: Fast Na⁺ block (lidocaine, mexiletine)
    • Class Ic: Slow Na⁺ block (flecainide, propafenone)

• Neuromuscular Blocking Agents

  • Depolarizing (succinylcholine): Persistent AChR activation

    • Phase I block: Depolarization → muscle fasciculations
    • Phase II block: Receptor desensitization after 5-10 minutes
    • Duration: 5-10 minutes (plasma cholinesterase hydrolysis)

  • Non-depolarizing: Competitive AChR antagonism

    • Rocuronium: Onset 60-90 seconds, duration 30-60 minutes
    • Reversal: Neostigmine (AChE inhibition) or sugammadex (direct binding)

⭐ Clinical Pearl: Succinylcholine is contraindicated in hyperkalemia, burns >24 hours old, or denervation injuries because upregulated AChRs cause massive K⁺ release (>2-3 mEq/L increase), potentially triggering cardiac arrest. Rocuronium + sugammadex provides rapid sequence alternative.

Diagnostic Electrophysiology Applications

Nerve and muscle physiology principles guide diagnostic testing interpretation:

• Nerve Conduction Studies

  • Motor conduction velocity: Normal >50 m/s in upper extremities
  • Sensory conduction velocity: Normal >50 m/s (faster than motor)
  • Compound muscle action potential: Normal >5 mV amplitude
    • Demyelination: Slowed conduction (<40 m/s), prolonged latencies
    • Axonal loss: Reduced amplitude (<50% normal), normal velocity

• Electromyography Patterns

  • Denervation: Fibrillations and positive sharp waves at rest
  • Myopathy: Small, polyphasic motor unit potentials
  • Neuropathy: Large, polyphasic potentials with reduced recruitment
    • Chronic denervation: Giant potentials (>5x normal amplitude)
    • Reinnervation: Increased polyphasia (>15% complex potentials)

💡 Master This: EMG changes follow predictable time courses - fibrillations appear 2-3 weeks after denervation, reinnervation potentials emerge 6-12 weeks later, and chronic changes stabilize >6 months. This timeline guides prognosis and surgical timing decisions.

Therapeutic Monitoring and Optimization

Physiological principles guide therapeutic drug monitoring and dose optimization:

• Neuromuscular Blockade Monitoring

  • Train-of-four ratio: >0.9 indicates adequate recovery
  • Post-tetanic count: Assesses deep blockade (no TOF response)
  • Double-burst stimulation: More sensitive than TOF for residual block

• Cardiac Electrophysiology Monitoring

  • QT interval: Rate-corrected QTc should be <450 ms (men), <470 ms (women)
  • Antiarrhythmic levels: Therapeutic windows based on protein binding
    • Lidocaine: 1.5-5.0 μg/mL (free drug concentration)
    • Digoxin: 1.0-2.0 ng/mL (steady-state after 5 half-lives)

Understanding the clinical integration of nerve and muscle physiology provides the foundation for accurate diagnosis of neuromuscular disorders, optimal anesthetic management, appropriate cardiac rhythm interpretation, and evidence-based therapeutic decision-making across multiple medical specialties.